Patents
Patents for C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
06/2001
06/12/2001US6245804 Contraceptives; urogenital disorders
06/06/2001CN1066718C Substituted aryloxy-alkyl diamines and its producing process and use
06/05/2001US6242422 (Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
05/2001
05/25/2001WO2001036388A1 Aza compounds having neuronal activity
05/25/2001CA2390071A1 Aza compounds having neuronal activity
05/23/2001EP1101763A2 Method for preparing sodium-hydrogen exchanger type 1 inhibitor
05/23/2001EP1100789A1 Substituted benzoylcyclohexandiones
05/22/2001US6235778 Anticoagulants
05/22/2001US6235752 Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptors
05/22/2001US6235748 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
05/22/2001US6235739 5-phenyl-3-pyridazinone derivatives and drug composition containing the same
05/17/2001WO2001034603A2 Bicyclic and tricyclic heteroaromatic compounds
05/17/2001WO2001034151A1 Novel topoisomerase poisons for the treatment of proliferative disorders
05/17/2001CA2388593A1 Bicyclic and tricyclic heteroaromatic compounds
05/16/2001EP1098886A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
05/16/2001CN1295562A Biocidal benzylbiphenyl derivatives
05/16/2001CN1295548A Novel tricyclic compound
05/16/2001CN1295070A Process for prep. of 1-type sodium-hydrogen exchange agent inhibitor
05/15/2001US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/15/2001US6232313 Pyridazino quinoline compounds
05/15/2001US6232057 Achieving enhanced sensitivity and reduced fog using iodide ion releasing compound which can release the iodide ion rapidly.
05/10/2001WO2001032631A2 Heterocyclic cytotoxic agents
05/10/2001WO2001032604A1 Activators of soluble guanylate cyclase
05/10/2001WO2000073276A3 Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, their production and their use as endothelin receptor antagonists
05/10/2001CA2389773A1 Activators of soluble guanylate cyclase
05/10/2001CA2389312A1 Heterocyclic cytotoxic agents
05/09/2001EP1097142A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
05/09/2001CN1065530C Process for prepn. of epsilon-caprolactam
05/03/2001WO2001030766A1 Phthalazinone derivatives as pde 4 inhibitors
05/03/2001CA2388121A1 Phthalazinone derivatives as pde 4 inhibitors
05/02/2001CN1293661A Pyridazinone hydrochloride compound and method for producing the same
05/01/2001US6225314 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
05/01/2001US6225313 Substituted 2-phenyl-3(2H)-pyridazinones
04/2001
04/29/2001CA2324640A1 Method for preparing sodium-hydrogen exchanger type 1 inhibitor
04/26/2001WO2001028560A1 A new use of levosimendan
04/24/2001US6221911 Reducing subcutaneous fat deposits in a subject; improving the skin condition of a subject
04/24/2001US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
04/24/2001US6221865 Inhibitors of protein farnesyltransferase and protein geranylgeranyltransferase.
04/18/2001EP1091937A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
04/18/2001EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
04/18/2001CN1291979A Novel pyridazine derivatives and drugs containing same as active ingredient
04/17/2001US6218426 For therapy of mammalian reproductive disorders and steroid hormone-dependent tumors as well as for regulating fertility, where suppression of gonadotropin release is indicated
04/17/2001US6218392 For therapy and prophylaxis of ischemic heart diseases such as angina pectoris, myocardial infarct and chronic and acute cardiac failure, pulmonary hypertension, arteriosclerosis and bronchial asthma
04/12/2001WO2001025229A1 Amide compounds
04/12/2001CA2386157A1 Amide compounds
04/11/2001EP1089967A1 Novel compounds useful in pain management
04/11/2001EP1089737A2 Method of treating pulmonary hypertension
04/11/2001CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives
04/10/2001US6215030 Catalytic reduction of acids, esters and anhydrides to alcohols
04/10/2001US6214835 Dihalopropene compounds insecticides containing them as active ingredients, and intermediates for their production
04/10/2001US6214810 Methods of treating or preventing cardiac arrhythmia
04/10/2001US6214809 Methods of treating or preventing cardiac arrhythmia
04/05/2001WO2001023375A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
04/04/2001EP1087956A2 A reference compound for use in the analysis of levosimendan batches
04/04/2001EP1087953A1 Nitrate salts of antihypertensive medicines
04/04/2001EP1087946A1 Aryl alkanoylpyridazines
04/04/2001EP1087941A2 Thiolesters and uses thereof
04/04/2001EP1087769A1 Use of a pyridazinone derative
04/04/2001CN1290249A Aminoguanidine hydrazone derivatives, process for producing the same and drugs thereof
04/03/2001US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates
03/2001
03/27/2001US6207667 1,3 diazines with platelet-derived growth factor receptor inhibitory activity
03/22/2001WO2001019822A1 Antiviral agents
03/22/2001CA2384898A1 Antiviral agents
03/20/2001US6204380 Production pyridazine herbicides
03/20/2001US6204293 Inhibitors of protein isoprenyl transferases
03/20/2001US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols
03/15/2001WO2001017972A2 Novel herbicides
03/14/2001EP1082309A1 Process for the preparation of a 3(2h)-pyridazinone- 4-substituted amino- 5-chloro- derivative
03/14/2001EP1082303A1 Heterocyclic derivatives which inhibit factor xa
03/14/2001EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/13/2001US6200971 For treating atherosclerosis
03/08/2001WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
03/07/2001CN1286254A Aromatic amino ether as analgesics
03/06/2001US6197785 Cardiovascular disorders
03/06/2001US6197782 Therapy for sexual disorders
03/06/2001US6197778 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
03/06/2001US6197750 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
02/2001
02/28/2001EP0792255B1 Liquid crystal compounds having perfluoroether terminal portions
02/28/2001CN1285825A Novel allylthiopyridazine derivatives and process for preparing the same
02/27/2001US6194577 Oxidizing 1-aminopyrrolidine in presence of inorganic base with air, oxygen or aqueous hydrogen peroxide as an oxidizing agent to form tetrahydropyridazine
02/27/2001US6194451 Prevent release tumor necrosis factor; antiinflammatory agents
02/15/2001WO2001010825A1 Carbamate derivatives and agricultural/horticultural bactericides
02/13/2001US6187920 Herbicides
02/13/2001US6187812 For controlling animal pests or harmful fungi; (e,e,e)-2-methoxyimino-2-(2'-(1?-methyl, 1?-(1?'-ethoxyiminoethyl))iminooxymethyl)phenylacetic acid monomethylamide, for example
02/08/2001WO2001009105A1 Method for the production of 4,6-dichloropyrimidine with the aid of phosgene
02/08/2001WO2000048446A3 Use of antagonists of pg-e for the treatment of neuropathic pain
02/08/2001CA2381608A1 Method for the production of 4,6-dichloropyrimidine with the aid of phosgene
02/07/2001CN1283190A Substituted benzene compounds, process for their preparation and herbicidal and defoliant composition containing them
02/01/2001WO2001007416A1 Method of producing pyridazine carboxylic acid derivatives
02/01/2001WO2001007415A1 Method of producing pyridazine-3,6-dicarboxylic acid esters
02/01/2001DE19935322A1 Verfahren zur Herstellung von 4,6-Dichlorpyrimidin mit Phosgen A process for preparing 4,6-dichloropyrimidine with phosgene
01/2001
01/31/2001CN1061346C Diazabicycloalkene derivatives and use, and drug composition containing said derivatives
01/30/2001US6180789 Method for obtaining pure enantiomers of a pyridazinone derivative
01/30/2001US6180629 [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
01/30/2001US6180628 Compounds, compositions and methods for treating influenza
01/25/2001WO2000058293A3 Glucokinase activators
01/24/2001EP1070056A1 Phthalazinone pde iii/iv inhibitors
01/24/2001EP1070055A1 Substituted phenyl pyridazinones
01/24/2001CN1281436A N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
01/23/2001US6177588 Having retinoid-like, retinoid antagonist or retinoid inverse agonist-like bioactivity; side effect reduction; skin disorders; antiproliferative and -carcinogenic agents; microbiocides; vision defects; cardiovascular disorders
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 85